Page 2 - Insulin

US President Biden pledges savings on insulin, other drugs for Americans

President Joe Biden pledged that his social agenda legislation would deliver tangible savings on prescription drugs for all Americans

USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug

Semglee may now be substituted for Sanofi's Lantus by a pharmacist in the US

Biocon set for bigger insulin play, aims to reach one in five diabetics

Biocon Biologics CEO says portfolio to form a substantial part of $1 bn revenue target, to roll out insulin Aspart by next year

Malaysia plant boosts Biocon prospects in US and other key markets

Firm seen benefiting from operating leverage, biologic sales by FY22

Biocon, Mylan win patent case for insulin device against Sanofi in US

Development takes Biocon a step closer to commercialise its glargine biosimilar Semglee in America

Diabetes to be our focus in India, US: Wockhardt's Habil Khorakiwala

Wockhardt is present in emerging markets like Mexico, Brazil with insulins

New form of insulin may improve clinical delivery of drug for diabetics

The researchers synthesised an insulin analogue called glycoinsulin, and demonstrated that it can also lower blood glucose levels in preclinical studies

Strides Pharma likely to launch affordable insulin from Stelis stable

The Bengaluru-headquartered company believes Stelis could be a disruptor in insulin accessibility and affordability.

Plastic ban: Biocon may replace disposable insulin pens with reusables

Biocon's ready-to-use pre-filled disposable pen with insulin Glargine is manufactured at its plant in Bengaluru

Inhalable insulin? Not yet

This is the latest in a series of setbacks in the research to find a less painful alternative to administer insulin

Many people inject insulin improperly

According to a new study, many patients were injecting insulin improperly, leading to worse glucose control, poorer outcomes and higher costs